Brief: Context Therapeutics Reports Q1 2022 Operating And Financial Results
11/05/2022 21:48
May 11 (Reuters) - Context Therapeutics Inc CNTX.O :
* CONTEXT THERAPEUTICS® REPORTS FIRST QUARTER 2022 OPERATING
AND
FINANCIAL RESULTS
* CONTEXT THERAPEUTICS - EXPECTS THAT ITS CASH AND CASH
EQUIVALENTS WILL BE SUFFICIENT TO FUND ITS OPERATIONS INTO 2024
* CONTEXT THERAPEUTICS - QTRLY LOSS PER SHARE $0.22
Source text for Eikon: ID:nGNX3kKVHJ
Further company coverage: CNTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Context Therapeutics
See all newsContext Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Context Therapeutics Q2 net loss widens on higher R&D costs
Context Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Brief: Context Therapeutics Announces Positive Interim Efficacy And Safety Results From Ongoing Phase 1 Clinical Trial For CTIM-76
Brief: Context Therapeutics Enters Into License Agreement Amendment With BioAtla For CT-202